Peripheral Venous CatheterizationNCT05647889
Pain and Anxiety in Peripheral Venous Catheterization, Jet Lidocaine, Ice Application
A study testing Jet lidocaine, Ice and Standard PVC procedure in people with Peripheral Venous Catheterization, run by Ataturk University at 2 sites in Turkey (Türkiye).
Trial summary
Investigation of the Effect of Jet Lidocaine and Ice Application on Pain and Anxiety in Peripheral Venous Catheterization (PVC). The research will be carried out experimentally with a single group post-test method. Read more about this study
- Who is it for?
- Ages 18 to 50 years
- Conditions the study is for
- Peripheral Venous Catheterization
- What is being tested?
- Jet lidocaine, Ice and Standard PVC procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 1 Jun 2022to 1 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Able to speak and understand Turkish,
- Those between the ages of 18-50,
- Demanding peripheral venous catheter insertion,
- Having lidocaine request before PVC,
- Having no problems with vision and hearing,
- No history of secondary acute pain other than peripheral venous catheter,
Show all 11Show fewer
- Having no physical barrier to insertion of a catheter from the cephalic veins,
- Not allergic to lidocaine and cold,
- No signs of phlebitis, scar tissue, dermatitis, incision and infection in the area to be operated,
- No history of peripheral nerve disease, peripheral neuropathy, paresis, plegia or hemiplegia that may affect the sensation of pain,
- Individuals without coagulation disorder, liver failure, kidney and cardiovascular failure will be included in the study.
Who cannot join
- Cannot speak or understand Turkish,
- Those who are outside the age range of 18-50,
- No request for peripheral venous catheter insertion,
- No lidocaine request before PVC,
- Having any problems with vision and hearing,
- Having a history of any secondary acute pain other than peripheral venous catheter,
Show all 11Show fewer
- Having a physical obstacle to insertion of a catheter from the cephalic veins,
- Those who are allergic to lidocaine and cold,
- With phlebitis, scar tissue, dermatitis, incision and infection findings in the area to be operated,
- Having a history of peripheral nerve disease, peripheral neuropathy, paresis, plegia or hemiplegia that may affect the sensation of pain,
- Patients with coagulation disorder, liver failure, kidney and cardiovascular failure
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
Ataturk University Faculty of Nursing
Erzurum, Centre, 25100
Gumushane Health Services Vocational School
Gümüşhane, Centre, 29100
About this study
Official title: Investigation of the Effect of Jet Lidocaine and Ice Application on Reduction of Pain and Anxiety Related to Peripheral Venous Catheterisation in Adult Patients: A Randomised Controlled Trial
Investigation of the Effect of Jet Lidocaine and Ice Application on Pain and Anxiety in Peripheral Venous Catheterization (PVC). The research will be carried out experimentally with a single group post-test method. The universe of the research; Between June-December 2022, all patients who need peripheral venous catheterization (PVK) for the treatment plan will be formed in the internal clinics of Gümüşhane State Hospital. The sample of the study will consist of 80 patients from the defined population who meet the inclusion criteria. Power analysis was used to determine the number of samples in the study. First of all, patients who are hospitalized in the internal clinics of Gümüşhane State Hospital and who meet the inclusion criteria will be determined. Written and verbal consent will be obtained for their participation by giving information about the research. PVK application will be applied to all patients by the same investigator. Each patient will create their own control group in order to control individual differences in pain and anxiety. In the study consisting of two intervention and a control group; The same patients will be included in the intervention groups and the control group. Randomization will be done to determine the order of intervention to be applied to the patients. The interventions for each patient will be numbered by the researcher and the order of procedure will be determined by drawing lots. After the cephalic vein for the first attempt is randomly determined, the other extremity vein will be used while performing consecutive PVC applications. To control the research in terms of bias; During the data collection phase, help will be taken from the clinical nurse who takes care of the patient. The nurse, who does not know which intervention is applied, will be asked to evaluate the patient's pain and anxiety. In this respect, the research will be considered single-blind.
Read the detailed description
This study was planned as a randomized controlled, single-blind experiment. The research will be carried out in the internal clinics of Gümüşhane State Hospital. Internal clinics were preferred because patients hospitalized in surgical clinics experienced intense pain and anxiety due to surgical operations. The universe of the research; All patients who are hospitalized in the relevant clinics within the specified time period and who need to apply PVC for the treatment plan will be formed.
The sample of the research; It will consist of 80 patients who are hospitalized in internal clinics, who need PVC for diagnosis or treatment, and who meet the research criteria. Power analysis was used to determine the number of samples in the study.The data of the research; Patient Information Form will be collected using the Visual Analog Scale for Pain (VAS-P), Visual Analog Scale for Anxiety (VAS-A), Wong-Baker Faces Pain Rating Scale. Nursing Intervention: The research will be conducted experimentally with a single group post-test method. First of all, patients who meet the criteria for inclusion in the study will be determined, and written and verbal consent will be obtained for their participation by giving information about the research. PVC application will be applied to all patients by the same investigator. Each patient will create their own control group in order to control individual differences in pain and anxiety. In the study consisting of two intervention and a control group; The same patients will be included in the intervention groups and the control group. Randomization will be done to determine the order of intervention to be applied to the patients. Interventions will be numbered for each patient and the order of procedure will be determined by drawing lots. After the cephalic vein for the first attempt is randomly determined, the other extremity vein will be used while performing consecutive PVC applications. To control the research in terms of bias; During the data collection phase, help will be taken from the clinical nurse who takes care of the patient. The nurse, who does not know which intervention is applied, will be asked to evaluate the patient's pain and anxiety. In this respect, the research will be considered single-blind.
Intervention group-I (Jet lidocaine will be applied before PVC and PVC will be performed 3 minutes later) Intervention group-II (Ice application will be made for 1 minute before PVC and then PVC will be performed) It will be named as the control group (Standard PVC procedure will be applied)
Process steps
Control group PVC Application Steps
- Hands will be washed.
- The treatment tray will be prepared.
- The correct patient will be determined, the procedure will be explained to the patient and permission will be obtained.
- A "Patient Identification Form" will be applied to the individual before PVC.
- The individual will be given a fowler, semi fowler or supine position.
- The area where PVC will be applied will be checked for phlebitis, thrombophlebitis, ecchymosis, hematoma and signs of local infection.
- The vein to be administered will be evaluated by observing and palpating in terms of intervention.
- By wearing gloves, the side grip sections of the peripheral venous catheter (22 G) will be brought to the horizontal position.
- A tourniquet will be attached 10-15 cm above the area where the catheter will be entered.
- The catheter will be held between the thumb and forefinger with the tapered side of the needle facing up.
- The individual will be asked to turn their head in the opposite direction to the side where the peripheral venous catheter will be inserted.
- Cleaning of the area will be done with a cotton pad with antiseptic in a single movement in the direction of arterial blood circulation and it will be waited for about 5 seconds for the area to dry.
- The catheter will be held at an angle of 30-45° to the skin, approximately 1 cm below the area where the vein is to be entered, and the vein will be accessed.
- As soon as the needle enters the vein, it will be slowly advanced into the vein, reducing the angle to approximately 15°.
- It will be checked whether there is blood coming to the blood stopper valve and if there is blood, the catheter will continue to be advanced in the vein.
- At this stage, the needle of the catheter will be withdrawn with the passive hand, while the plastic part will be advanced into the vein with the active hand simultaneously.
- The level of pain related to the PVC application during the insertion of the catheter will be evaluated by the clinical nurse with the Wong-Baker Faces Pain Rating Scale.
- Without moving the catheter in the vein, the tourniquet will be loosened with the inactive hand, fixed temporarily with a small patch, the needle of the catheter will be removed and the cap of the catheter will be closed.
- Permanent fixation of the catheter will be performed.
- Contaminated materials will be removed from the environment.
- Within 1 minute after catheter placement, patients' pain and anxiety levels related to PVC application will be evaluated with VAS-A and VAS-P.
Intervention group-I PVC Application Steps
- Implementation steps 1-7 of the Control Group will be done.
- A tourniquet will be tied 10-15 cm above the area where the catheter will be inserted by wearing gloves.
- After the area to be intervened is determined, the tourniquet will be dissolved, the area will be cleaned with a cotton pad with antiseptic from top to bottom in a single movement, and the area will be waited for 5 seconds to dry.
- The dermis layer on the vein determined for intervention will be pulled to the side with the help of the passive hand (without any venous intervention), and the head of the lidocaine-loaded jet device will be firmly placed on the cit at an angle of 90°.
- Since 0.3 ml of lidocaine solution or 3 mg of total dose will not pose a problem in terms of drug toxicity; 0.3 ml 1% lidocaine will be applied with a Jet device and waited for 5 seconds.
- After waiting for 5 seconds, the Jet device will be lifted and the skin will be released.
- Catheter intervention will be performed after 3 min to achieve optimal anesthetic conditions.
- The lateral grips of the peripheral venous catheter (22 G) will be placed in the horizontal position.
- The process will be completed by performing the steps between 9-11 and 13-21 of the Control Group.
Initiative Group-II PVC Application Steps
- Implementation steps of the Control Group 1-7 will be done.
- In order to create an anesthetic effect; Ice will be applied for 1 minute to the designated area to enter before PVC.
- The process will be completed by performing the 8-21 application steps of the Control Group.Variables of the Study Dependent variables were: Visual Analog Scale Score for Anxiety (VAS-A), Visual Analog Scale Score for Pain (VAS-P), and Wong-Baker Faces Pain Rating Scale Score.
Independent variables:
0.3 ml Jet lidocaine application before peripheral venous catheterization
1 minute ice application before peripheral venous catheterization
Control variables:
Peripheral venous catheterization site (Cephalic vein), Catheter diameter and length (22 G)
Evaluation of data: The data will be evaluated in the SPSS (Statistical Package for Social Sciences for Windows, Version 22.0) package program. In the evaluation of the data, the statistical significance value will be accepted as 0.05, the Type 1 error will be kept at 5% and the evaluation will be made with a 95% confidence interval
- Conditions
- Peripheral Venous Catheterization
- Being tested
- Jet lidocaine, Ice, Standard PVC procedure
- Keywords
- Pain, Anxiety, Ice application, Jet Lidocaine, Nursing, Peripheral venous catheterization
- Medical subject headings
- Pain, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Jet lidocaineDrug
Also called Intervention group-I
Jet lidocaine will be applied before PVC and PVC will be performed 3 minutes later.
IceCombination product
Also called Intervention group-II
Ice will be applied for 1 minute before PVC, and then PVC will be performed.
Standard PVC procedureOther
Also called standard application group
Standard PVC procedure will be applied
| Study group | Role | What they receive |
|---|---|---|
| Jet lidocaine group | Experimental | Jet lidocaine will be applied before PVC and PVC will be performed 3 minutes later. Receives: Drug: Jet lidocaine |
| Ice group | Experimental | Ice will be applied for 1 minute before PVC, and then PVC will be performed. Receives: Combination Product: Ice |
| Control group | Active comparator | Standard PVC procedure will be applied Receives: Other: Standard PVC procedure |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analogue Scale for Pain (VAS-P)
It is a scale used to evaluate the severity of pain. It is a 100 mm ruler with painlessness at one end and the most severe pain at the other. "0" denotes painlessness, and "100" denotes the most severe pain.A low score from the scale indicates that the application is beneficial.
Measured: Within 1 minute after PVC application
Secondary outcomes (1)
Visual Analogue Scale for Anxiety (VAS-A)
VAS-A; It consists of a continuous horizontal line 0-100 mm long. "0" represents I am not nervous at all, while "100" represents I am extremely nervous. Participants indicate their level of anxiety by specifying a position between the two extremes.A low score from the scale indicates that the application is beneficial.
Measured: Within 1 minute after PVC application
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Dec 2022
- Study start1 Jun 2022
- Primary completion31 Dec 2022
- Study completion1 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Peripheral Venous CatheterizationStudies of the same condition, open and under way.
- More trials run by Ataturk UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- In the study, 80 individuals, including 2 experimental and 1 control group, were included in the study.
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ataturk University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esra Aydın, Ataturk University
- Investigators
- Esra Aydın, Principal investigator, esraaydin@gumushane.edu.tr-0456 2331149Gülçin Avşar, Study director, gulcin.avsar@atauni.edu.tr-0 442 2311584
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05647889
- Sponsor's protocol ID
- ATATURKUNIVERSITYESRAAYDIN0029
- Status last verified
- Apr 2025
- First submitted
- 20 Oct 2022
- Last updated
- 30 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Effect of Jet Lidocaine and Ice Application on Reduction of Pain and Anxiety Related to Peripheral Venous Catheterisation in Adult Patients: A Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT05647889
- Acronym / sponsor ID
- ATATURKUNIVERSITYESRAAYDIN0029
- Conditions
- Peripheral Venous Catheterization
- Keywords
- Pain, Anxiety, Ice application, Jet Lidocaine, Nursing, Peripheral venous catheterization
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Ataturk UniversityUniversity, hospital or other
- Study start
- 1 Jun 2022 (actual)
- Primary completion
- 31 Dec 2022 (actual)
- Study completion
- 1 Sep 2023 (actual)
- First posted
- 13 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigation of the Effect of Jet Lidocaine and Ice Application on Pain and Anxiety in Peripheral Venous Catheterization (PVC). The research will be carried out experimentally with a single group post-test method. The universe of the research; Between June-December 2022, all patients who need peripheral venous catheterization (PVK) for the treatment plan will be formed in the internal clinics of Gümüşhane State Hospital. The sample of the study will consist of 80 patients from the defined population who meet the inclusion criteria. Power analysis was used to determine the number of samples in the study. First of all, patients who are hospitalized in the internal clinics of Gümüşhane State Hospital and who meet the inclusion criteria will be determined. Written and verbal consent will be obtained for their participation by giving information about the research. PVK application will be applied to all patients by the same investigator. Each patient will create their own control group in order to control individual differences in pain and anxiety. In the study consisting of two intervention and a control group; The same patients will be included in the intervention groups and the control group. Randomization will be done to determine the order of intervention to be applied to the patients. The interventions for each patient will be numbered by the researcher and the order of procedure will be determined by drawing lots. After the cephalic vein for the first attempt is randomly determined, the other extremity vein will be used while performing consecutive PVC applications. To control the research in terms of bias; During the data collection phase, help will be taken from the clinical nurse who takes care of the patient. The nurse, who does not know which intervention is applied, will be asked to evaluate the patient's pain and anxiety. In this respect, the research will be considered single-blind.
Detailed description
This study was planned as a randomized controlled, single-blind experiment. The research will be carried out in the internal clinics of Gümüşhane State Hospital. Internal clinics were preferred because patients hospitalized in surgical clinics experienced intense pain and anxiety due to surgical operations. The universe of the research; All patients who are hospitalized in the relevant clinics within the specified time period and who need to apply PVC for the treatment plan will be formed.
The sample of the research; It will consist of 80 patients who are hospitalized in internal clinics, who need PVC for diagnosis or treatment, and who meet the research criteria. Power analysis was used to determine the number of samples in the study.The data of the research; Patient Information Form will be collected using the Visual Analog Scale for Pain (VAS-P), Visual Analog Scale for Anxiety (VAS-A), Wong-Baker Faces Pain Rating Scale. Nursing Intervention: The research will be conducted experimentally with a single group post-test method. First of all, patients who meet the criteria for inclusion in the study will be determined, and written and verbal consent will be obtained for their participation by giving information about the research. PVC application will be applied to all patients by the same investigator. Each patient will create their own control group in order to control individual differences in pain and anxiety. In the study consisting of two intervention and a control group; The same patients will be included in the intervention groups and the control group. Randomization will be done to determine the order of intervention to be applied to the patients. Interventions will be numbered for each patient and the order of procedure will be determined by drawing lots. After the cephalic vein for the first attempt is randomly determined, the other extremity vein will be used while performing consecutive PVC applications. To control the research in terms of bias; During the data collection phase, help will be taken from the clinical nurse who takes care of the patient. The nurse, who does not know which intervention is applied, will be asked to evaluate the patient's pain and anxiety. In this respect, the research will be considered single-blind.
Intervention group-I (Jet lidocaine will be applied before PVC and PVC will be performed 3 minutes later) Intervention group-II (Ice application will be made for 1 minute before PVC and then PVC will be performed) It will be named as the control group (Standard PVC procedure will be applied)
Process steps
Control group PVC Application Steps
- Hands will be washed.
- The treatment tray will be prepared.
- The correct patient will be determined, the procedure will be explained to the patient and permission will be obtained.
- A "Patient Identification Form" will be applied to the individual before PVC.
- The individual will be given a fowler, semi fowler or supine position.
- The area where PVC will be applied will be checked for phlebitis, thrombophlebitis, ecchymosis, hematoma and signs of local infection.
- The vein to be administered will be evaluated by observing and palpating in terms of intervention.
- By wearing gloves, the side grip sections of the peripheral venous catheter (22 G) will be brought to the horizontal position.
- A tourniquet will be attached 10-15 cm above the area where the catheter will be entered.
- The catheter will be held between the thumb and forefinger with the tapered side of the needle facing up.
- The individual will be asked to turn their head in the opposite direction to the side where the peripheral venous catheter will be inserted.
- Cleaning of the area will be done with a cotton pad with antiseptic in a single movement in the direction of arterial blood circulation and it will be waited for about 5 seconds for the area to dry.
- The catheter will be held at an angle of 30-45° to the skin, approximately 1 cm below the area where the vein is to be entered, and the vein will be accessed.
- As soon as the needle enters the vein, it will be slowly advanced into the vein, reducing the angle to approximately 15°.
- It will be checked whether there is blood coming to the blood stopper valve and if there is blood, the catheter will continue to be advanced in the vein.
- At this stage, the needle of the catheter will be withdrawn with the passive hand, while the plastic part will be advanced into the vein with the active hand simultaneously.
- The level of pain related to the PVC application during the insertion of the catheter will be evaluated by the clinical nurse with the Wong-Baker Faces Pain Rating Scale.
- Without moving the catheter in the vein, the tourniquet will be loosened with the inactive hand, fixed temporarily with a small patch, the needle of the catheter will be removed and the cap of the catheter will be closed.
- Permanent fixation of the catheter will be performed.
- Contaminated materials will be removed from the environment.
- Within 1 minute after catheter placement, patients' pain and anxiety levels related to PVC application will be evaluated with VAS-A and VAS-P.
Intervention group-I PVC Application Steps
- Implementation steps 1-7 of the Control Group will be done.
- A tourniquet will be tied 10-15 cm above the area where the catheter will be inserted by wearing gloves.
- After the area to be intervened is determined, the tourniquet will be dissolved, the area will be cleaned with a cotton pad with antiseptic from top to bottom in a single movement, and the area will be waited for 5 seconds to dry.
- The dermis layer on the vein determined for intervention will be pulled to the side with the help of the passive hand (without any venous intervention), and the head of the lidocaine-loaded jet device will be firmly placed on the cit at an angle of 90°.
- Since 0.3 ml of lidocaine solution or 3 mg of total dose will not pose a problem in terms of drug toxicity; 0.3 ml 1% lidocaine will be applied with a Jet device and waited for 5 seconds.
- After waiting for 5 seconds, the Jet device will be lifted and the skin will be released.
- Catheter intervention will be performed after 3 min to achieve optimal anesthetic conditions.
- The lateral grips of the peripheral venous catheter (22 G) will be placed in the horizontal position.
- The process will be completed by performing the steps between 9-11 and 13-21 of the Control Group.
Initiative Group-II PVC Application Steps
- Implementation steps of the Control Group 1-7 will be done.
- In order to create an anesthetic effect; Ice will be applied for 1 minute to the designated area to enter before PVC.
- The process will be completed by performing the 8-21 application steps of the Control Group.Variables of the Study Dependent variables were: Visual Analog Scale Score for Anxiety (VAS-A), Visual Analog Scale Score for Pain (VAS-P), and Wong-Baker Faces Pain Rating Scale Score.
Independent variables:
0.3 ml Jet lidocaine application before peripheral venous catheterization
1 minute ice application before peripheral venous catheterization
Control variables:
Peripheral venous catheterization site (Cephalic vein), Catheter diameter and length (22 G)
Evaluation of data: The data will be evaluated in the SPSS (Statistical Package for Social Sciences for Windows, Version 22.0) package program. In the evaluation of the data, the statistical significance value will be accepted as 0.05, the Type 1 error will be kept at 5% and the evaluation will be made with a 95% confidence interval
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Single blind (care provider)
- Number of arms
- 3
- Model description
- In the study, 80 individuals, including 2 experimental and 1 control group, were included in the study.
| Arm | Type | Receives |
|---|---|---|
| Jet lidocaine group | Experimental | Drug: Jet lidocaineJet lidocaine will be applied before PVC and PVC will be performed 3 minutes later. |
| Ice group | Experimental | Combination Product: IceIce will be applied for 1 minute before PVC, and then PVC will be performed. |
| Control group | Active comparator | Other: Standard PVC procedureStandard PVC procedure will be applied |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (11 listed)
- Able to speak and understand Turkish,
- Those between the ages of 18-50,
- Demanding peripheral venous catheter insertion,
- Having lidocaine request before PVC,
- Having no problems with vision and hearing,
Key exclusion criteria (11 listed)
- Cannot speak or understand Turkish,
- Those who are outside the age range of 18-50,
- No request for peripheral venous catheter insertion,
- No lidocaine request before PVC,
- Having any problems with vision and hearing,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Jet lidocaineAlso: Intervention group-IJet lidocaine will be applied before PVC and PVC will be performed 3 minutes later. | Drug | Jet lidocaine group |
| IceAlso: Intervention group-IIIce will be applied for 1 minute before PVC, and then PVC will be performed. | Combination product | Ice group |
| Standard PVC procedureAlso: standard application groupStandard PVC procedure will be applied | Other | Control group |
Primary outcome
Visual Analogue Scale for Pain (VAS-P)
Time frame: Within 1 minute after PVC application
It is a scale used to evaluate the severity of pain. It is a 100 mm ruler with painlessness at one end and the most severe pain at the other. "0" denotes painlessness, and "100" denotes the most severe pain.A low score from the scale indicates that the application is beneficial.
1 secondary outcome
Visual Analogue Scale for Anxiety (VAS-A)
Time frame: Within 1 minute after PVC application
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Peripheral Venous Catheterization
Enrolling by invitation
TruVascular Access - Ultrasound-Guided Vascular Access Study
Peripheral Venous Catheterization, Difficult Intravenous Access
Recruiting
Comparison of the Effectiveness of Ultrasound-guided Techniques and Infrared Illumination, Compared With the Standard Approach to Peripheral Venous Line Placement in People With Difficult Venous Access
Peripheral Venous Catheterization
Not yet recruiting
Immersive VR to Reduce Stress, Anxiety, and Pain During PICC/Midline Placement
Vasoconstriction, Biomarkers
Not yet recruiting
Palm Stimulator Use During Peripheral Venous Catheterization
Procedural Pain, Cancer
Recruiting
The Effect of Video-Based Virtual Reality Education on Self-Confidence and Motivation in Nursing Students
Peripheral Venous Catheterization, Nursing Students
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Esra Aydın principal investigator
esraaydin@gumushane.edu.tr-0456 2331149
Gülçin Avşar study director
gulcin.avsar@atauni.edu.tr-0 442 2311584
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Jet lidocaine, Ice and Standard PVC procedure in people with Peripheral Venous Catheterization, run by Ataturk University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analogue Scale for Pain (VAS-P) (time frame: Within 1 minute after PVC application). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025; AzTrials last refreshed its copy on 8 Nov 2026.